Meta-analyses suggest modest improvements in depression scores and quality-of-life measures, but causality remains unclearbenefits may reflect weight loss, improved metabolic health, or direct neural effects
Professor Ania Jastreboff, MD, PhD Yale University provided an overview #ADA2026 of the TRIUMPH-1 trial for Retatrutide, the investigational triple G medicine from Eli Lilly and Company The unique trial design provided insights beyond #weightloss #obesity and also encompassed relevant endpoints for co-morbidities such as knee osteoarthritis and obstructive sleep apnea, two comorbidities highly sensitive to weight loss
Skip treatment if you have an active or recent cancer , uncontrolled diabetes , severe heart disease, untreated endocrine disorders, or if you are pregnant or breastfeeding
No, tirzepatide is not indicated for the treatment of type 1 diabetes
Drinking it too late in the day could interfere with sleep, especially for those who are sensitive to caffeine
The global market for supplements grew 7.5% in 2021, ending that year at nearly $60 billion a figure that dwarfed predictions issued before the pandemic, according to the Nutrition Business Journal
